Migrainous infarction …

Shuu-Jiun Wang MD

Headache & Pain

Updated 04.08.2024
Released 07.01.1993
Expires For CME 04.08.2027

Migrainous infarction

Author: Shuu-Jiun Wang MD

See Contributor Disclosures

Migrainous infarction

In This Article

Quick Link

Introduction

Overview

In this article, the author updates the topic of migrainous infarction, including the diagnostic criteria proposed by the International Classification of Headache Disorders, 3rd edition, 2018.

Key points

	• Migrainous infarction is a rare complication after usual attacks of migraine with aura with documentation of neuroimaging findings, such as MRI. Cortical laminar necrosis is one of the MRI findings.
	• The incidence of migrainous infarction is very rare, estimated at 3.36 per 100,000 person-years according to the strict criteria proposed by the International Headache Society. It is mandatory to exclude cerebral infarctions in cases where patients experience an atypical aura even in the context of established migraine.
	• Migrainous infarction mostly occurs in the posterior circulation and in younger women with a history of migraine with aura.
	• The majority of patients present with visual prolonged aura, and the stroke severity is mild with good short-term and long-term outcomes.
	• Several mechanisms are proposed to link migraine and stroke, with genetic predisposition, aura-related electrophysiological mechanisms (cortical spreading depolarization), and cerebral microembolism being the most convincing ones.
	• The pathologic mechanisms responsible for migrainous infarction remain unproven, and a continuum between migraine aura and stroke by cortical spreading depolarization is suggested.
	• Post-stroke headache, which is different from migrainous infarction, is not considered rare and ranges from 1% to 23% after ischemic stroke.

Historical note and terminology

Migraine attacks are occasionally accompanied by stroke. Permanent neurologic deficits associated with attacks of migraine were reported as early as the 19th century. Charcot first used the term "complicated migraine" (13), and Galezowski reported persistent visual sequelae (21). Hunt wrote a classic paper concerned with permanent paralysis along with other neurologic complications of migraine (27).

The diagnosis of migrainous infarction is based on the abrupt onset of a neurologic deficit during a migraine attack associated with evidence of cerebral infarction on neuroimaging. Other causes of stroke must be excluded. Strict criteria for the diagnosis of migrainous infarction must be applied because migraine is common and patients with migraine may suffer from other causes of stroke. It is mandatory to exclude cerebral infarctions in cases where patients experience an atypical aura even in the context of established migraine (24). The diagnosis of migrainous infarction should be made only when a patient with an established history of migraine suffers a cerebral infarction during a typical migraine attack (54).

Clinical manifestations

Presentation and course

The diagnostic criteria of migrainous infarction were proposed by the International Classification of Headache Disorders, third edition (ICHD-III), as follows (coded as 1.4.3) (23):

	(A) A migraine attack fulfilling criteria B and C
	(B) Occurring in a patient with 1.2 migraines with aura and typical of previous attacks except that one or more aura symptoms persist for more than 60 minutes
	(C) Neuroimaging demonstrates ischemic infarction in a relevant area
	(D) Not better accounted for by another diagnosis

The most common clinical scenario is of a patient who has had frequent attacks of migraine headache preceded by temporary hemianopia. Following a particularly severe attack, the deficit persists, and the patient is left with a permanent loss of vision in one visual field. This visual field deficit may regress gradually over the following months, ultimately leaving a clearly defined area of permanent visual field loss. The next most common signs of migrainous infarction are hemiparesis, monoparesis, and hemisensory symptoms, characteristically having the cheiro-oral distribution (ie, involving the digits and the side of the mouth). Less frequently, neurologic deficits include ataxia or persistent dysphasia. Although persistent neurologic symptoms associated with migraine are usually visual and localized to the region of the cerebral cortex supplied by the posterior cerebral arteries, ischemic strokes attributable to migraine also commonly occur within the territory of the middle cerebral artery. A rare case with right-side occipital infarction presented as persistent visual aura for 1 week without visual defect (67). Lee and colleagues reported rare auditory symptoms as initial symptoms in two patients with migrainous infarctions (35). Brain MRI showed infarction over the upper pons and cerebellum in one patient and negative findings in the other. Hoekstra-van Dalen reported that migrainous infarction is a stroke entity that causes mostly infarcts in the occipital lobe (26). Migrainous infarction involving the bilateral anterior cerebral artery territory has been reported (17). Tang and colleagues reported two patients with migrainous infarctions that involved two different cerebral arteries (66). A 29-year-old woman developed infarctions over the right posterior cerebral artery and right anterior choroidal artery simultaneously, and a 47-year-old man developed two episodes of migrainous infarction within 4 years involving the territories of the middle and posterior cerebral arteries sequentially. Even though migrainous infarction is considered more common in those younger than 45 years old, a 93-year-old woman was reported to suffer from migrainous infarction (71). In one unusual case, a 47-year-old man with visual aura was reported, who developed early recurrence of migrainous infarction— one in the cerebellum and the other in the occipital lobe (52). Chhabra and colleagues reported two rare patients with migraine with retinal aura, who developed migrainous infarction as retinal or optic nerve infarction (15). Catarci reported a 74-year-old man who developed right-side occipital ischemic stroke after visual snow phenomenon (10). His visual snow symptoms changed from bilateral and temporary to left-sided and permanent one day on awakening. The patient denied a history of migraine with aura, and his persistent visual snow disappeared completely after about 1 year.

Arboix and colleagues reported nine consecutive patients with migrainous infarction diagnosed according to the strict criteria of the International Headache Society (04). Their mean age was 35.7±12 years. Six patients (67%) were women. All suffered from headache at the onset of neurologic deficit. The stroke manifested as limb weakness in five patients, sensory symptoms in five patients, hemianopia in four patients, nausea and vomiting in four patients, and aphasia in one patient. Six patients had a cerebral infarct visible on neuroimaging studies (in the territory of the middle cerebral artery in three patients, posterior cerebral artery in two patients, and superior cerebellar artery in one patient). The neuroimaging studies of the remaining three patients showed negative findings even though the patients’ neurologic deficit lasted at least 7 days.

Two large series, one from Germany (n=17) (76) and the other from Finland (n=33) (34), showed that migrainous infarction most commonly occurs in younger women with a history of migraine with aura. Most patients presented with prolonged visual aura (82%). The severity of the stroke was mild, with an NIH Stroke Scale score of 2. A total of 70.6% to 82% of patients had acute ischemic lesions in the posterior circulation. The prognosis was usually good. The differentiation between prolonged aura and migrainous infarction was difficult and was associated with delayed admission of patients to the hospital.

One clinical phenotype that was first introduced with proposed criteria in the ICHD-3, persistent post-stroke headache (coded as 6.1.1.2 Persistent headache attributed to past ischemic stroke [cerebral infarction]), was considered not uncommon, ranging from 1% to 23% after ischemic stroke (23; 11).

Prognosis and complications

In general, the long-term prognosis for patients with migrainous infarction is good. Milhaud and colleagues, in a prospective stroke registry, found that the outcome at 1 month was favorable in more than 70% of migraineurs with ischemic stroke (44). Arboix and colleagues reported that the mean length of hospital stay of nine consecutive patients with migrainous infarction was 9.75±6.2 days. No patients died during hospital stay, and 67% were symptom-free at discharge (04). Rothrock and colleagues followed 28 patients with migrainous stroke for a mean of 25.3 months. There were six recurrent strokes. The researchers reported that migrainous stroke itself showed comparatively poor prognosis for risk of recurrent stroke, and stroke recurrence rates of previous reports have been lower because the patient populations involved were either smaller than theirs or were followed for shorter intervals (53). It is of interest that Linetsky and colleagues reported six patients with migrainous infarction whose headache frequency and severity decreased after ischemic stroke (39). They hypothesized that the improvement in migraine may be due to reduced nociceptive transmission as the result of loss in vasoreactivity of the affected cerebral blood vessels. Two large series both showed a very favorable prognosis in patients with migrainous infarction (34; 76). A long-term study of 15 patients with migrainous infarction, mean age of 34.8 years, showed a favorable outcome in 80% of patients with a mean follow-up duration of 7.5 years.

Clinical vignette

A 32-year-old woman who worked as a laborer suffered from severe migraine for 1 week. This was followed by weakness in her limbs on the left side. She denied hypertension or any other cardiovascular risk factors and was not on oral contraceptives. Her usual pattern was one or two attacks of migraine without aura per month and, rarely, migraine with visual aura. During the week she had severe headaches and noted a visual aura (bright light) over her left visual field that lasted for 30 minutes. This lasted longer than her previous auras, and 2 hours later she noted transient left limb weakness that lasted for approximately 30 minutes. When she awoke the next day, her headache was less severe, but her left limbs were paralyzed. Neurologic examination showed left hemianopia and left hemiparesis (muscle power grade 1 to grade 2) with hyperreflexia and Babinski sign. MRI of the brain showed acute cerebral infarction over the right frontotemporal region compatible with MCA occlusion. MRA showed occlusion of the M1 segment of the right middle cerebral artery but no vasospasm. The patient had a normal electrocardiogram, cardiac echogram, carotid artery duplex sonography, ANA, prothrombin time, APTT, protein S, protein C, and anticardiolipin antibody. She was discharged on verapamil 240 mg once per day and aspirin 100 mg per day. In 6 months, she had recovered enough to walk without aid. At the 4-year follow-up, she still had occasional migraine without aura and infrequent migraine with aura. No recurrence of stroke was noted.

Biological basis

Etiology and pathogenesis

The exact cause of migrainous infarction is still not certain. Based on studies using cerebral angiography during attacks, the most important underlying mechanism for the stroke is believed to be carotid or vertebral arterial spasm resulting in a critical degree of cerebral hypoperfusion (20; 54; 55). However, this may not always be true, so other factors should be considered.

Occasionally, drug therapy is considered to be a contributing or precipitating factor. For many years, ergotamine overdoses have been thought to cause constriction of the cerebral vessels. Propranolol has also been reported to be related to permanent neurologic defects in some patients, particularly if the drugs induced postural hypotension among elderly patients (51). This relationship, however, is not well established. Mendizabal and colleagues reported a case of migrainous stroke in which treatment with propranolol was associated with stroke onset and may have played a causative role (40). Oral contraceptives, particularly in high doses, have been found to greatly increase the incidence of migrainous cerebral infarction, especially in young women (12; 44). Serotonergic medications were perhaps responsible for ischemia and the subsequent stroke (45; 64).

It is possible that some migraineurs’ strokes are a result of microemboli associated with these disorders (47). Patent foramen ovale, a potential source of paradoxical cerebral embolism, was found to be more frequent in young patients with migraine with aura (01). Milhaud and colleagues found that patent foramen ovale is an independent risk factor for ischemic stroke in young migraineurs (44). Wolf and colleagues found a high frequency in a German series (64.7%) (76). However, Laurell and colleagues did not show an increased frequency (40%) (34). Carerj and colleagues reported a higher prevalence of atrial septal aneurysm in patients with migraine with aura than in patients with migraine without aura and controls, suggesting that atrial septal aneurysm may play a part in cryptogenic stroke in migraineurs (09). Other investigators have related carotid or vertebral artery dissection to cerebral infarction in patients with migraine.

The pathologic mechanisms responsible for cerebral infarction remain unproven; arterial vasospasm (with cerebral edema), arterial wall dissection, and increased platelet aggregation are the most likely candidates. Other factors may contribute to migrainous infarction, but extracranial or intracranial vasospasm is believed to play a major role.

Fifty years ago, Wolff and his coworkers suggested that arterial vasospasm was the primary cause of the aura preceding the migraine attack (77). This vascular theory of migraine has been supported by studies of cases of "complicated migraine" and migrainous infarction where prodromes have persisted and cerebral infarction has been documented. All investigators agree that attacks are accompanied by reduced cerebral blood flow during the aura. Meyer and colleagues reported significant reductions in regional cerebral blood flow during the prodromal interval with 133Xe inhalation (43). The evidence that vasospasm is the primary cause of the symptoms of migrainous aura is supported by regional cerebral blood flow measurements, arteriographic data, and limited autopsy studies demonstrating the absence of intrinsic vascular or cardiac disease despite extensive brain infarction.

It is possible that patients with migrainous infarction have rheological abnormalities predisposing to platelet aggregation, coagulation disorders, and intravascular thrombosis. Welch contends that "spreading oligemia" can lead to platelet accumulation in hypoperfused cerebral areas (74). Vasoactive substances released by platelets could further reduce cerebral blood flow to ischemic levels. The proportion of platelet microaggregates in the circulation has been shown to be greater than in control individuals during the prodromal period of an attack. Augmentation of this intrinsic platelet abnormality by extrinsic factors (eg, oral contraceptives, alcohol abuse, cigarette smoking, and diabetes mellitus) combined with intrinsic conditions (eg, mitral valve prolapse or migrainous vasospasm) are probable factors in the genesis of migrainous strokes. The frequent presence of antiphospholipid antibodies and lupus anticoagulant in young patients with stroke has suggested that these factors play an important part in migrainous stroke (63). However, this finding remains controversial (69). Santos and colleagues reported a 43-year-old woman who developed migraine aura-like symptoms before developing right-side, middle cerebral artery ischemic infarction (56). During operation, several episodes of cortical spreading depression were recorded with increasing levels of glutamate and lactate/pyruvate ratio. This case provided a link between migraine aura and stroke by cortical spreading depolarization.

The von Willebrand factor, a large, multimeric glycoprotein acting as a procoagulant via stimulation of platelet adherence, activation, and aggregation, has been purported to be an independent risk factor for ischemic stroke. The role of von Willebrand factor in migrainous infarction was explained by Tietjen and colleagues, who found that migraineurs with or without prior stroke had significantly higher von Willebrand factor antigen and activity than controls (68). Proinflammatory platelet adhesion to leukocytes occurring during the headache-free interval in patients with migraine is similar to that seen in those with acute coronary or cerebrovascular syndromes (78). This may support the hypothesis that migraine attacks predispose to stroke by inducing platelet-related hypercoagulability.

According to the ICHD-3, migrainous infarction has to occur in patients with migraine with aura. It is possible that the mechanisms underlying migrainous infarction and migraine with prolonged aura might be the same. However, a study adopting 31P-MR spectroscopy found the cortical energy reserve in patients with migrainous infarction was similar to that in controls but higher than in patients with migraine with prolonged aura (59).

Wolf and colleagues found that acute ischemic lesions in patients with migrainous infarction were often multiple and located in distinct arterial territories and that there were no overlapping ischemic lesions; therefore, they suggest that hemodynamic compromise during the development of migraine is unlikely to be the cause of infarction (76). Chen and Eikermann-Haerter, in a comprehensive review, suggest that the mechanisms linking migraine and stroke connection are multifactorial, with genetic predisposition, aura-related electrophysiological mechanisms (cortical spreading depolarization), and cerebral microembolism being the most convincing ones (14).

Epidemiology

The incidence of migrainous infarction is rare, according to the strict criteria proposed by the International Headache Society. Henrich and colleagues reported that the incidence rate of first migrainous infarction was 3.36 per 100,000 person-years (25). However, in the absence of other stroke risk factors, this estimate was reduced to 1.44 per 100,000 person-years. In a study of the Barcelona Stroke Registry, Arboix and colleagues reported that the group of patients with migrainous infarction accounted for only 0.6% of all first-ever acute strokes, 0.8% of ischemic strokes, 12.8% of ischemic strokes of unusual etiology, and 13.7% of ischemic strokes in young adults 45 years of age or younger (04). Therefore, stroke can occur during migraine attacks, but the association between migraine and stroke is infrequent (06; 70). It was also reported that ischemia-induced migraine attacks may be more frequent than migraine-induced ischemic insults (48). A large series in Germany found 17 patients among 8137 patients with stroke (0.2%) over an 11-year period (76).

Unlike the rare epidemiological survey of migrainous infarction, the association between migraine and stroke has been well documented (08; 41; 72). A case-control study in young women also revealed that oral contraceptives, high blood pressure, and smoking were high-risk factors for infarction in migraineurs (12). Schwaag and colleagues repeated this association that migraine was a significant risk factor for juvenile stroke in Germany (61). The risk was even higher in people younger than 35 years of age and in females. In a cross-sectional study, migraineurs, particularly those who had migraine with aura, had a higher cerebrovascular risk than individuals without a history of migraine (58). By following a cohort of the Women’s Health Study for a mean of 9.9 years, Kurth and colleagues demonstrated that migraine with aura but not without aura was associated with about a two-fold increased risk of ischemic stroke as well as myocardial infarction and ischemic cardiovascular death and a 1.7-fold increased risk of coronary revascularization (30). Compared with women without migraine, Kurth and colleagues observed a J-shaped relationship between migraine frequency and cardiovascular events, with a higher risk for very infrequent (< monthly) and frequent migraine attacks (> or = weekly) and a lower risk for monthly migraine (32). The risk was only increased for women with migraine with aura. Stroke was associated with migraine with aura and a migraine frequency of at least one per week. The prospective data from the Physicians’ Health Study also indicate an increased risk of stroke in men with migraine (RR: 1.84; 95% CI: 1.10–3.08) who were aged 40 to 45 years at study entry. This association was not found in older age groups (31). The same group further demonstrated that the association between migraine with aura and cardiovascular disease varies by vascular risk status. The association was strongest in the lowest cardiovascular risk score group stratified by the Framingham risk score (33). A meta-analysis confirmed the association between migraine aura and stroke but not myocardial infarction (60).

MRI has been successfully used to evaluate clinical and subclinical lesions in the brain. Subclinical cerebral lesions, especially in the posterior circulation or white matter, were reported to be more frequent in patients with migraine (especially migraine with aura) in a case-control MRI study, ie, CAMERA (Cerebral Abnormalities in Migraine, an Epidemiological Risk Analysis) study (29). The same group, in another study, demonstrated that most (88%) infratentorial infarct-like lesions had a vascular border zone location in the cerebellum and, further, that a combination of (possibly migraine attack-related) hypoperfusion and embolism is the likeliest mechanism for posterior circulation infarction in migraine (28). Scher and colleagues studied the association between migraine in middle age and late-life infarct-like lesions in a prospective, large, population-based cohort, ie, Age Gene/Environment Susceptibility (AGES)-Reykjavik Study from Iceland (57). After on average 25 years, subjects with migraine with aura had increased odds of late-life infarct-like lesions on MRI (OR=1.4), a result entirely driven by an association of migraine with aura and cerebellar lesions among women (OR=1.9). There was no association between migraine without aura or nonmigraine headache with the infarct-like brain lesions.

Diagnostic workup

Because distinct diagnostic criteria are lacking, migrainous infarction should be considered a diagnosis of exclusion. The diagnosis demands a well-established history of migraine and exclusion of other conditions that cause stroke. Computed tomography, MRI (including diffusion-weighted image, perfusion-weighted image, MRS, and MRA), cerebral arteriography, transcranial Doppler evaluations, and transesophageal echocardiography evaluations should be performed when possible. Lumbar puncture and blood studies to help exclude vasculitis should also be carried out.

MRI techniques provide more information for acute cerebral infarction and may be the diagnostic tool of choice for migrainous infarction (46), particularly if the clinical examination demonstrates brainstem or cerebellar signs. It might also be useful in patients with prolonged aura (65). It has been reported that elevation of cerebral lactate can be detected among patients with migrainous infarction by localized 1H MRS (73). Liang and Scott (37) reported a patient with migrainous infarction whose MRI showed cortical laminar necrosis. The authors hypothesized that sluggish perfusion combined with a variety of metabolic derangements (spreading depression in the case of migraine) probably accounted for this unusual finding. Two patients with migrainous infarction showed cortical laminar necrosis in their MRI studies (03; 50). Arai and associates reported on the chronological changes in neuroimaging findings in a 64-year-old man with migrainous infarction (02). Of note, the MRI abnormalities suggested the presence of vasogenic edema, prolonged hyperperfusion, and alteration of the blood-brain barrier followed by irreversible brain damage.

When carried out at the time of the acute process, cerebral arteriography often reveals abnormalities during migrainous stroke. Dukes and Vieth first reported angiographic observations in migraine with aura (19). Sequential angiography made during the prodromal phase showed progressive decreases in the caliber of the internal carotid arterial system. Lieberman and colleagues reported a case of complicated "diplegic migraine" with angiographic demonstration of vasospasm of both the cervical carotid and intracranial middle cerebral arteries (38). However, cerebral arteriography carries a significant complication rate, and the risk-to-benefit ratio should be carefully weighed in the acute stages of presumed migrainous infarction.

Gomez and colleagues reported an interesting case of a young woman with a longstanding history of migraine with aura who developed acute cerebellar infarction in association with reversible vasospasm of the vertebral arteries (22). The vasospasm was demonstrated by transcranial Doppler sonography. However, the differential diagnosis of thunderclap headache with vasospasm should also be considered in this case (18).

References

01: Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura. A transcranial Doppler study. Neurology 1999;52:1622-5. PMID 10331688
02: Arai S, Utsunomiya H, Arihiro S, Arakawa S. Migrainous infarction in an adult: evaluation with serial diffusion-weighted images and cerebral blood flow studies. Radiat Med 2008;26(5):313-7. PMID 18661217
03: Arboix A, González-Peris S, Grivé E, Sánchez MJ, Comes E. Cortical laminar necrosis related to migrainous cerebral infarction. World J Clin Cases 2013;1(8):256-9. PMID 24340278
04: Arboix A, Massons J, Garcia-Eroles L, Oliveres M, Balcells M, Targa C. Migrainous cerebral infarction in the Sagrat Cor Hospital of Barcelona stroke registry. Cephalalgia 2003;23:389-94. PMID 12780770
05: Arboix A, Massons J, Oliveres M, Arribas MP, Titus F. Headache in acute cerebrovascular disease: a prospective clinical study in 240 patients. Cephalalgia 1994;14:37-40. PMID 8200024
06: Bousser MG. Migraine, female hormones, and stroke. Cephalalgia 1999;19:75-9. PMID 10214531
07: Bousser MG, Conard J, Kittner S, et al. Recommendations on the risk of ischemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. Cephalalgia 2000;20(3):155-6. PMID 10997767
08: Buring JE, Hebert P, Romero J, et al. Migraine and subsequent risk of stroke in the Physician's Health Study. Arch Neurol 1995;52(2):129-34. PMID 7848119
09: Carerj S, Narbone MC, Zito C, et al. Prevalence of atrial septal aneurysm in patients with migraine: an echocardiographic study. Headache 2003;43(7):725-8. PMID 12890126
10: Catarci T. Occipital ischaemic stroke after visual snow phenomenon - a case report. Cephalalgia 2021;41(7):871-4. PMID 33435707
11: Chan M, Thaler A. Post-stroke headache. Curr Pain Headache Rep 2023;27(11):673-8. PMID 37676411
12: Chang CL, Donaghy M, Poulter N. Migraine and stroke in young women: case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ 1999;318(7175):13-8. PMID 9872876
13: Charcot JM. Sur un cas de migraine ophtalmoplegique. Prog Med 1890;1:83-4.
14: Chen SP, Eikermann-Haerter K. How imaging can help us better understand the migraine-stroke connection. Headache 2020;60(1):217-28. PMID 31579941
15: Chhabra N, Chiang CC, Di Nome MA, et al. Migrainous infarction of the eye: Two cases of monocular ischemic complications associated with retinal migraine. Cephalalgia 2022;42(6):553-6. PMID 34786973
16: Collaborative Group for the Study of Stroke in Young Women. Oral contraceptives and stroke in young women: associated risk factors. JAMA 1975;231(7):718-22. PMID 1172861
17: Demirkaya S, Odabasi Z, Gokcil Z, Ozdag F, Kutukcu Y, Vural O. Migrainous stroke causing bilateral anterior cerebral artery territory infarction. Headache 1999;39(7):513-6. PMID 11279938
18: Dodick DW. Thunderclap headache. Curr Pain Headache Rep 2002;6:226-32. PMID 12003694
19: Dukes HT, Vieth RG. Cerebral arteriography during migraine prodrome and headache. Neurology 1964;14:636-9. PMID 14200038
20: Featherstone HJ. Clinical features of stroke in migraine: a review. Headache 1986;26:128-33. PMID 3700087
21: Galezowski X. Ophthalmic megrim; an affection of the vasomotor nerves of the retina and retinal center, which may end in thrombosis. Lancet 1881;1:176-8.
22: Gomez CR, Gomez SM, Puricelli MS, Malik MM. Transcranial Doppler in reversible migrainous vasospasm causing cerebellar infarction: report of a case. Angiology 1991;42:152-6. PMID 2006761
23: Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 3rd edition. Cephalalgia 2018;38:1-211. PMID 29368949
24: Hebant B, Simmonet L, Moal JL, Guegan-Massardier E. Solving the conundrum. A migrainous infarction or an infarct-induced migrainous attack? J Postgrad Med 2019;65(3):181-3. PMID 31210144
25: Henrich JB, Sandercock PA, Warlow CP, Jones LN. Stroke and migraine in the Oxfordshire community stroke project. J Neurol 1986;233:257-62. PMID 3772405
26: Hoekstra-van Dalen RA, Cillessen JP, Kappelle LJ, van Gijn J. Cerebral infarcts associated with migraine: clinical features, risk factors and follow-up. J Neurol 1996;243:511-5. PMID 8836940
27: Hunt RJ. A contribution to the paralytic and other persistent sequelae of migraine. Am J Med Sci 1915;150:313-30.
28: Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain 2005;128:2068-77. PMID 16006538
29: Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-34. PMID 14747499
30: Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-91. PMID 16849661
31: Kurth T, Gaziano JM, Cook N, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007;167:795–801. PMID 17452542
32: Kurth T, Schurks M, Logroscino G, Buring JE. Migraine frequency and risk of cardiovascular disease in women. Neurology 2009;73(8):581-8. PMID 19553594
33: Kurth T, Schurks M, Logroscino G, Gaziano JM, Buring JE. Migraine, vascular risk, and cardiovascular events in women: a prospective cohort study. BMJ 2008;337:a636. PMID 18687721
34: Laurell K, Artto V, Bendtsen L, et al. Migrainous infarction: a Nordic multicenter study. Eur J Neurol 2011;18(10):1220-26. PMID 21414105
35: Lee H, Whitman GT, Lim JG, et al. Hearing symptoms in migrainous infarction. Arch Neurol 2003;60:113-6. PMID 12533097
36: Leira R. Migraine due to infarct. Neurologia 1997;12(S5):16-23. PMID 9498853
37: Liang Y, Scott TF. Migrainous infarction with appearance of laminar necrosis on MRI. Clin Neurol Neurosurg 2007;109:592-6. PMID 17537570
38: Lieberman AN, Jonas S, Hass WK, et al. Bilateral cervical carotid and intracranial vasospasm causing ischemia in a migrainous patient: a case of 'diplegic migraine.' Headache 1984;24(5):245-8. PMID 6490360
39: Linetsky E, Leker RR, Ben-Hur T. Headache characteristics in patients after migrainous stroke. Neurology 2001;57:130-2. PMID 11445642
40: Mendizabal JE, Greiner F, Hamilton WJ, Rothrock JF. Migrainous stroke causing thalamic infarction and amnesia during treatment with propranolol. Headache 1997;37:594-6. PMID 9385761
41: Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N. Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 1997;54:362-8. PMID 9109736
42: Meyer JS. Calcium channel blockers in the prophylactic treatment of vascular headache. Ann Intern Med 1985;102:395-7. PMID 3970475
43: Meyer JS, Kawamura J, Terayama Y. Xenon 133 cerebral blood flow measurements in migraine with aura. In: Olesen J, editor. Migraine and other headaches: the vascular mechanism. New York: Raven, 1991:115-9.
44: Milhaud D, Bogousslavsky J, van Melle G, Liot P. Ischemic stroke and active migraine. Neurology 2001;57:1805-11. PMID 11723268
45: Molaie M. Serotonin syndrome presenting with migrainelike stroke. Headache 1997;37:519-21. PMID 9329236
46: Neumann-Haefelin T, Moseley ME, Albers GW. New magnetic resonance imaging methods for cerebrovascular disease: emerging clinical applications. Ann Neurol 2000;47:559-70. PMID 10805325
47: Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 2010;67:221-9. PMID 20225282
48: Olesen J, Friberg L, Olsen TS, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993;116(Pt 1):187-202. PMID 8453456
49: O'Quinn S, Davis RL, Gutterman DL, Pait GD, Fox AW. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine. Cephalalgia 1999;19(4):223-31. PMID 10376167
50: Parks NE, Rigby HB, Gubitz GJ, Shankar JJ, Purdy RA. Dysmetropsia and Cotard's syndrome due to migrainous infarction - or not. Cephalalgia 2014;34(9):717-20. PMID 24646835
51: Prendes JL. Consideration on the use of propranolol in complicated migraine. Headache 1980;20:93-5. PMID 7372478
52: Renard D, Nerrant E, Freitag C. Early recurrence of migrainous infarction. Acta Neurol Belg 2015;115(4):675-6. PMID 25687371
53: Rothrock J, North J, Madden K, Lyden P, Fleck P, Dittrich H. Migraine and migrainous stroke: risk factors and prognosis. Neurology 1993;43:2473-6. PMID 8255442
54: Rothrock JF, Walicke P, Swenson MR. Migrainous stroke. Arch Neurol 1988;45:63-7. PMID 3337678
55: Sanin LC, Mathew NT. Severe diffuse intracranial vasospasm as a cause of extensive migrainous cerebral infarction. Cephalalgia 1993;13:289-92. PMID 8374945
56: Santos E, Sánchez-Porras R, Dohmen C, Hertle D, Unterberg AW, Sakowitz OW. Spreading depolarizations in a case of migraine-related stroke. Cephalalgia 2012;32:433-6. PMID 22407661
57: Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009;301(24):2563-70. PMID 19549973
58: Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614-20. PMID 15728281
59: Schulz UG, Blamire AM, Davies P, Styles P, Rothwell PM. Normal cortical energy metabolism in migrainous stroke: a 31P-MR spectroscopy study. Stroke 2009;40:3740-4. PMID 19834021
60: Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis.BMJ 2009;339:b3914. PMID 19861375
61: Schwaag S, Nabavi DG, Frese A, Husstedt IW, Evers S. The association between migraine and juvenile stroke: a case-control study. Headache 2003;43:90-5. PMID 12558760
62: Shuaib A. Stroke from other etiologies masquerading as migrainous-stroke. Stroke 1991;22:1068-74. PMID 1866754
63: Silvestrini M, Matteis M, Troisi E, Cupini LM, Zaccari G, Bernardi G. Migrainous stroke and the antiphospholipid antibodies. Eur Neurol 1994;34:316-9. PMID 7851451
64: Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002;58:130-3. PMID 11781419
65: Smith M, Cros D, Sheen V. Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura. Neurology 2002;58:1308-10. PMID 11971111
66: Tang SC, Jeng JS, Liu HM, Yip PK. Migrainous infarction involving two different arterial territories: report of two cases. Acta Neurol Taiwan 2004;13:20-3. PMID 15315297
67: Thissen S, Koehler PJ. Persistent aura with small occipital cortical infarction: implications for migraine pathophysiology. Case Rep Neurol 2014;6(2):217-21. PMID 25298768
68: Tietjen GE, Al-Qasmi MM, Athanas K, Dafer RM, Khuder SA. Increased von Willebrand factor in migraine. Neurology 2001;57:334-6. PMID 11468324
69: Tietjen GE, Day M, Norris L, et al. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurological events: a prospective study. Neurology 1998;50(5):1433-40. PMID 9596001
70: Tzourio C, Kittner SJ, Bousser MG, Alperovich A. Migraine and stroke in young women. Cephalalgia 2000;20:190-9. PMID 10997773
71: Tzoulis CH, Naess H, Thomassen L. Migrainous cerebral infarction in a previously healthy 93-year-old female patient with no risk factors for stroke. Cephalalgia 2006;26:894-5. PMID 16776710
72: Wang SJ, Chen PK, Fuh JL. Comorbidities of migraine. Front Neurol 2010;1:16. PMID 21188255
73: Watanabe H, Kuwabara T, Ohkubo M, Sakai K, Tsuji S. Elevation of cerebral lactate detected by localized 1H magnetic resonance spectroscopy in a patient with migraine. Clin Neurol 1994;34:504-7. PMID 7924068
74: Welch KM. Migraine. A bio-behavioral disorder. Arch Neurol 1987;44:323-7. PMID 3827684
75: Wiebers DO. Ischemic cerebrovascular complications of pregnancy. Arch Neurol 1985;42:1106-13. PMID 2864911
76: Wolf ME, Szabo K, Griebe M, et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology 2011;76(22):1911-7. PMID 21624990
77: Wolff HG, Tunis MM, Goodell H. Evidence of tissue damage and changes to pain sensitivity in subjects with vascular headaches of the migraine type. Arch Intern Med 1953;92:478-85. PMID 13136278
78: Zeller JA, Lindner V, Frahm K, Baron R, Deuschl G. Platelet activation and platelet-leucocyte interaction in patients with migraine. Subtype differences and influence of triptans. Cephalalgia 2005;25:536-41. PMID 15955041

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Shuu-Jiun Wang MD

Dr. Wang of the Brain Research Center, National Yang-Ming University, and the Neurological Institute, Taipei Veterans General Hospital, has no relevant financial relationships to disclose.
See Profile

Former Authors

John Stirling Meyer MD
Katsuyuki Obara MD
Shizuko Konno MD
Li-Chi Hsu

Patient Profile

Age range of presentation: 6 to 65+ years
Sex preponderance: female>male, >2:1
Heredity: heredity may be a factor
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Migrainous infarction

Associated Disorders

Blood dyscrasia
Cardiac dysrhythmias
Collagen disease
Diabetes mellitus
Hypertension
- Mitral valve prolapse
- Prinzmetal angina

Differential Diagnosis

arterial dissection
arteriovenous malformation
cardioembolic stroke
intracranial neoplasm
idiopathic thunderclap headache
- severe intractable headache
- marantic endocarditis
- generalized atherosclerosis associated with diabetes

Also Relevant

Headache associated with ischemic cerebrovascular disease
Migraine
Hormonal contraception and stroke

Clinical Categories

Headache & Pain

Patient Handouts

Web References

Guidelines

AAN: Headache

Migrainous infarction …

Migrainous infarction

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Special considerations

Pregnancy

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Headache associated with intracranial neoplasms

Acupuncture

Migraine in childhood

Headache attributed to head trauma

Migraine: pathogenesis and pathophysiology

Tension-type headache

Benign paroxysmal vertigo

Vagal nerve stimulation for headaches

Migrainous infarction

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Special considerations

Pregnancy

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Headache associated with intracranial neoplasms

Acupuncture

Migraine in childhood

Headache attributed to head trauma

Migraine: pathogenesis and pathophysiology

Tension-type headache

Benign paroxysmal vertigo

Vagal nerve stimulation for headaches

This is an article preview.
Start a Free Account
to access the full version.